InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.91
(
0.53%
)
Bitcoin
59,775.55
(
-3.63%
)
Post# of 252474
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 82360

Tuesday, 10/20/2009 2:49:34 PM

Tuesday, October 20, 2009 2:49:34 PM

Post# of 252474
BPAX/LibiGel more safety data in Phase III program

An independent data monitoring committee reviewed all unblinded adverse events in the safety study of LibiGel. There have been no deaths, one myocardial infarction and three breast cancers reported in the study. The committee recommended the continuation of the trial.

http://www.reuters.com/article/marketsNews/idCNBNG24088920091020?rpc=44
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up